Skip to Main Content

Author Details

David Pauck
German Cancer Research Center (DKFZ)
2017
14
6
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36639156Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation.J Immunother Cancer2023
37057673De novo missense variants in RRAGC lead to a fatal mTORopathy of early childhood.Genet Med2023
37215954UBE2C promotes leptomeningeal dissemination and is a therapeutic target in brain metastatic disease.Neurooncol Adv2023
36127323Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors.Cell Death Dis2022
35831316The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors.Nat Commun2022
35993110Sensitivity towards HDAC inhibition is associated with RTK/MAPK pathway activation in gastric cancer.EMBO Mol Med2022
34628166Longitudinal stability of molecular alterations and drug response profiles in tumor spheroid cell lines enables reproducible analyses.Biomed Pharmacother2021
34584066The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma.Cell Death Dis2021
32451331A Cell-Based MAPK Reporter Assay Reveals Synergistic MAPK Pathway Activity Suppression by MAPK Inhibitor Combination in <i>BRAF</i>-Driven Pediatric Low-Grade Glioma Cells.Mol Cancer Ther2020
33333810Different Calculation Strategies Are Congruent in Determining Chemotherapy Resistance of Brain Tumors In Vitro.Cells2020
30848061Effective and safe tumor inhibition using vinblastine in medulloblastoma.Pediatr Blood Cancer2019
31081944The long noncoding RNA TP73-AS1 promotes tumorigenicity of medulloblastoma cells.Int J Cancer2019
28002790Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing.Oncotarget2017
28571041CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells.Br J Cancer2017
  • 1 - 14 of 14

Recommended Authors

Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2016
Number of shared co-authors 13
University of California San Diego
Career Start Year 2013
Number of shared co-authors 8
The Chinese University of Hong Kong, Prince of Wales Hospital
Career Start Year 2010
Number of shared co-authors 17
St. Jude Children's Research Hospital
Career Start Year 2010
Number of shared co-authors 20
University of Michigan-Ann Arbor
Career Start Year 2010
Number of shared co-authors 8
St Jude Children's Research Hospital
Career Start Year 2009
Number of shared co-authors 19
Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University
Career Start Year 2009
Number of shared co-authors 22
University of Texas MD Anderson Cancer Center Houston
Career Start Year 2009
Number of shared co-authors 17
Texas Children's Cancer Center, Baylor College of Medicine
Career Start Year 2008
Number of shared co-authors 9
Dana-Farber Cancer Institute
Career Start Year 2008
Number of shared co-authors 17
McMaster Stem Cell and Cancer Research Institute
Career Start Year 2006
Number of shared co-authors 7
The Research Institute of the McGill University Health Centre, McGill University
Career Start Year 2003
Number of shared co-authors 17
Arnold Palmer Hospital for Children
Career Start Year 2003
Number of shared co-authors 14
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 2002
Number of shared co-authors 2
Seve Ballesteros Foundation Brain Tumor group
Career Start Year 2002
Number of shared co-authors 5
McMaster University
Career Start Year 2001
Number of shared co-authors 13
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 22
Brain Tumor Institute, Children's National Hospital
Career Start Year 1998
Number of shared co-authors 13
University of Illinois at Urbana-Champaign
Career Start Year 1996
Number of shared co-authors 5
NYU Grossman School of Medicine
Career Start Year 1995
Number of shared co-authors 6
Stanford University
Career Start Year 1994
Number of shared co-authors 4
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1994
Number of shared co-authors 4
Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer
Career Start Year 1994
Number of shared co-authors 22
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Career Start Year 1993
Number of shared co-authors 23
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 18
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Career Start Year 1992
Number of shared co-authors 16
Arthur and Sonia Labatt Brain Tumor Research Centre, Hospital for Sick Children
Career Start Year 1990
Number of shared co-authors 20
Huntsman Cancer Institute, University of Utah
Career Start Year 1990
Number of shared co-authors 12
University of California san francisco
Career Start Year 1985
Number of shared co-authors 21
The Hospital for Sick Children
Career Start Year 1980
Number of shared co-authors 21

Collaborators

and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 13
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 9
Groupe Hospitalier Universitaire Pitie-Salpetriere
Co-authored papers 8
German Cancer Research Center (DKFZ)
Co-authored papers 7
Heinrich Heine University
Co-authored papers 6
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Co-authored papers 5
German Cancer Research Center (DKFZ)
Co-authored papers 4
Institute of Neuropathology, Heinrich-Heine University Dusseldorf
Co-authored papers 4
Universitatsklinikum
Co-authored papers 4
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Co-authored papers 4
German Cancer Research Center (DKFZ)
Co-authored papers 4
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 4
German Cancer Research Center (DKFZ)
Co-authored papers 4
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 3
Institute of Neuropathology, Heinrich Heine University
Co-authored papers 3
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 3
Universitatsklinikum
Co-authored papers 3
Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN)
Co-authored papers 2
Heinrich-Heine University Dusseldorf
Co-authored papers 2
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 2
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 2
Hospital for Sick Children
Co-authored papers 2
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 2
Ben-Gurion University of the Negev
Co-authored papers 2
University Hospital and University of Zurich
Co-authored papers 1
Institut fur Pysikalische Biologie, Heinrich Heine University Dusseldorf
Co-authored papers 1
Stanford University
Co-authored papers 1
Institut fur Physikalische Biologie, Heinrich-Heine-Universitat Dusseldorf
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1